PL1761779T3 - Zastosowanie transtyretyny jako biomarkera gruczolaka jelita grubego; sposób wykrywania i układ testowy - Google Patents

Zastosowanie transtyretyny jako biomarkera gruczolaka jelita grubego; sposób wykrywania i układ testowy

Info

Publication number
PL1761779T3
PL1761779T3 PL04764118T PL04764118T PL1761779T3 PL 1761779 T3 PL1761779 T3 PL 1761779T3 PL 04764118 T PL04764118 T PL 04764118T PL 04764118 T PL04764118 T PL 04764118T PL 1761779 T3 PL1761779 T3 PL 1761779T3
Authority
PL
Poland
Prior art keywords
colorectal
transthyretin
colorectal adenoma
biomarker
detection
Prior art date
Application number
PL04764118T
Other languages
English (en)
Inventor
Hartmut Juhl
Kerstin David
Original Assignee
Indivumed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34958684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1761779(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indivumed Gmbh filed Critical Indivumed Gmbh
Publication of PL1761779T3 publication Critical patent/PL1761779T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL04764118T 2004-08-13 2004-08-13 Zastosowanie transtyretyny jako biomarkera gruczolaka jelita grubego; sposób wykrywania i układ testowy PL1761779T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04764118A EP1761779B1 (en) 2004-08-13 2004-08-13 Use of transthyretin as a biomarker for colorectal adenoma ; method for detection and test system
PCT/EP2004/009124 WO2006015616A1 (en) 2004-08-13 2004-08-13 Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system

Publications (1)

Publication Number Publication Date
PL1761779T3 true PL1761779T3 (pl) 2008-04-30

Family

ID=34958684

Family Applications (2)

Application Number Title Priority Date Filing Date
PL04764118T PL1761779T3 (pl) 2004-08-13 2004-08-13 Zastosowanie transtyretyny jako biomarkera gruczolaka jelita grubego; sposób wykrywania i układ testowy
PL05772471T PL1776587T3 (pl) 2004-08-13 2005-08-11 Zastosowanie C3A i jego pochodnych jako biomarkera do leczenia gruczolaka i/lub raka jelita grubego; metody diagnostyczne i testy z ich użyciem

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL05772471T PL1776587T3 (pl) 2004-08-13 2005-08-11 Zastosowanie C3A i jego pochodnych jako biomarkera do leczenia gruczolaka i/lub raka jelita grubego; metody diagnostyczne i testy z ich użyciem

Country Status (20)

Country Link
US (2) US7951528B2 (pl)
EP (3) EP1843159A1 (pl)
JP (2) JP4916441B2 (pl)
KR (1) KR20070051328A (pl)
CN (2) CN101014859A (pl)
AT (2) ATE376674T1 (pl)
AU (2) AU2004322162B2 (pl)
BR (1) BRPI0419002A (pl)
CA (2) CA2577601A1 (pl)
DE (2) DE602004009716T2 (pl)
DK (2) DK1761779T3 (pl)
ES (2) ES2295907T3 (pl)
IL (2) IL181131A (pl)
MX (2) MX2007001479A (pl)
NO (2) NO20070598L (pl)
PL (2) PL1761779T3 (pl)
PT (2) PT1761779E (pl)
SI (1) SI1776587T1 (pl)
WO (2) WO2006015616A1 (pl)
ZA (1) ZA200701188B (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004322162B2 (en) 2004-08-13 2011-04-28 Indivumed Gmbh Use of transthyretin as a biomarker for colorectal adenoma; method for detection and test system
EP1775590A1 (en) * 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
JP4748671B2 (ja) * 2006-03-16 2011-08-17 日東紡績株式会社 食道扁平上皮癌マーカーおよびそれを利用した食道扁平上皮癌の判定方法
KR100819122B1 (ko) 2006-09-30 2008-04-04 남명진 췌장암 진단용 키트
JP5570810B2 (ja) * 2007-08-18 2014-08-13 学校法人北里研究所 大腸癌マーカポリペプチド、及び大腸癌の診断方法
JP5203687B2 (ja) * 2007-12-12 2013-06-05 シスメックス株式会社 動物検査情報提供システム、中央装置、動物検査情報提供方法及びコンピュータプログラム
CN101838683B (zh) * 2008-12-12 2013-09-18 深圳华大基因科技有限公司 一种kras基因和/或braf基因的核苷酸突变位点的检测方法
CN102147396B (zh) * 2010-02-10 2014-01-01 桑建利 人血液样本中脂类分子含量测定及其结直肠腺瘤诊断试剂盒制备与应用
JP2013253780A (ja) * 2010-10-12 2013-12-19 Katakura Industries Co Ltd うつ病の診断のためのデータの提供方法
US10158898B2 (en) 2012-07-26 2018-12-18 Comcast Cable Communications, Llc Customized options for consumption of content
MX2015006757A (es) * 2012-11-30 2015-11-30 Applied Proteomics Inc Método para la evaluación de la presencia de o riesgo de tumores de colon.
CN104056277B (zh) * 2013-03-21 2019-07-05 中国人民解放军第二军医大学 Mlh1基因或其表达产物在dkk4高表达的结直肠癌中的应用
US20170176441A1 (en) * 2014-03-28 2017-06-22 Applied Proteomics, Inc. Protein biomarker profiles for detecting colorectal tumors
CN107110865B (zh) * 2014-08-22 2020-01-10 雅培制药有限公司 用于结肠直肠癌的早期检测的方法
CN105988006A (zh) * 2015-02-10 2016-10-05 张曼 尿液补体c3蛋白的应用
EP3281016A1 (en) 2015-04-10 2018-02-14 Applied Proteomics Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
US20180092874A1 (en) * 2016-10-03 2018-04-05 Lincoln Memorial University Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment
KR102018205B1 (ko) * 2017-07-24 2019-09-05 (주) 바이오인프라생명과학 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법
GB201721569D0 (en) * 2017-12-21 2018-02-07 Belgian Volition Sprl Method for the detection and treatment of colorectal adenomas
GB201808476D0 (en) * 2018-05-23 2018-07-11 Univ Liverpool Biomarkers for colorectal cancer
WO2021072275A1 (en) 2019-10-11 2021-04-15 Guardant Health, Inc. Use of cell free bacterial nucleic acids for detection of cancer
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
EP4407042A3 (en) 2020-07-10 2024-09-18 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
US20230280349A1 (en) * 2022-03-01 2023-09-07 The University Of Chicago Methods of Differentiating a Malignant Tumor from a Non-Malignant Tumor
CN116449018B (zh) * 2023-02-14 2023-09-05 浙江大学 一种用于肠腺瘤腺癌诊断的血浆蛋白标记物及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996298A (en) * 1988-04-20 1991-02-26 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US5654161A (en) 1995-05-12 1997-08-05 Chiron Diagnostics Corporation Method for diagnosing prostate cancer
US6221621B1 (en) 1997-03-06 2001-04-24 Bard Diagnostic Sciences, Inc. Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated
DE19711111C2 (de) 1997-03-06 1999-09-02 Schering Ag In vitro Nachweis zur Erkennung von Darmtumoren
IL121134A0 (en) 1997-06-22 1997-11-20 Yeda Res & Dev Peptides and antiallergic compositions comprising them
US20020160394A1 (en) 2001-01-24 2002-10-31 Bayer Corporation Regulation of transthyretin to treat obesity
WO2003000182A2 (en) 2001-06-22 2003-01-03 Merck & Co., Inc. Ppar-alpha ligands for the treatment or prevention of cachexia
US7144708B2 (en) * 2001-06-25 2006-12-05 The Cleveland Clinic Foundation Markers of blood barrier disruption and methods of using same
DE10224534A1 (de) 2002-05-31 2003-12-11 Juergen Dolderer Verfahren zum Diagnostizieren des colorektaien Karzinoms in einer Gewebeprobe und Mittel zur Behandlung
CA2499709A1 (en) 2002-06-19 2003-12-31 Yoichi Furukawa Method for diagnosis of colorectal tumors
DE60332639D1 (de) * 2002-08-06 2010-07-01 Univ Johns Hopkins Verwendung von biomarkern zum nachweis von eierstockkrebs
CA2526878A1 (en) * 2003-04-08 2004-10-21 Colotech A/S A method for detection of colorectal cancer in human samples
US7268117B2 (en) 2003-07-11 2007-09-11 Praecis Pharmaceuticals Incorporated Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
ES2334671T3 (es) 2004-08-13 2010-03-15 Egomedical Technologies Ag Sistema de ensayo de analitos para determinar la concentracion de un analito en un fluido fisiologico o acuoso.
AU2004322162B2 (en) 2004-08-13 2011-04-28 Indivumed Gmbh Use of transthyretin as a biomarker for colorectal adenoma; method for detection and test system
US9075062B2 (en) 2005-03-22 2015-07-07 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Identification of biomarkers by serum protein profiling

Also Published As

Publication number Publication date
MX2007001479A (es) 2007-07-25
JP2008509407A (ja) 2008-03-27
JP4592753B2 (ja) 2010-12-08
PT1776587E (pt) 2009-04-03
NO20070599L (no) 2007-05-14
US20080160515A1 (en) 2008-07-03
EP1843159A1 (en) 2007-10-10
JP4916441B2 (ja) 2012-04-11
BRPI0419002A (pt) 2007-12-11
DK1776587T3 (da) 2009-04-20
CA2577601A1 (en) 2006-02-16
EP1761779B1 (en) 2007-10-24
EP1761779A1 (en) 2007-03-14
DE602004009716D1 (de) 2007-12-06
JP2008509409A (ja) 2008-03-27
NO20070598L (no) 2007-05-14
SI1776587T1 (sl) 2009-06-30
AU2004322162B2 (en) 2011-04-28
US20070184499A1 (en) 2007-08-09
ATE376674T1 (de) 2007-11-15
KR20070051328A (ko) 2007-05-17
DE602004009716T2 (de) 2008-08-28
IL181132A0 (en) 2007-07-04
DK1761779T3 (da) 2008-02-25
AU2005306103A1 (en) 2006-05-26
IL181131A0 (en) 2007-07-04
EP1776587A1 (en) 2007-04-25
PL1776587T3 (pl) 2009-06-30
ZA200701188B (en) 2009-01-28
EP1776587B9 (en) 2009-09-16
ES2295907T3 (es) 2008-04-16
CA2576998A1 (en) 2006-05-26
US7951528B2 (en) 2011-05-31
ES2322378T3 (es) 2009-06-19
WO2006015616A1 (en) 2006-02-16
DE602005012108D1 (de) 2009-02-12
CN101014859A (zh) 2007-08-08
AU2004322162A1 (en) 2006-02-16
PT1761779E (pt) 2008-02-01
US7883842B2 (en) 2011-02-08
IL181132A (en) 2011-04-28
CN101014861A (zh) 2007-08-08
AU2004322162A2 (en) 2006-02-16
ATE419534T1 (de) 2009-01-15
WO2006053592A1 (en) 2006-05-26
IL181131A (en) 2011-03-31
MX2007001254A (es) 2007-10-05
EP1776587B1 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
IL181132A0 (en) Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
WO2008134526A3 (en) Glycoprotein profiling of bladder cancer
WO2005041893A3 (en) Detection of acute myocardial infarction biomarkers
WO2007035690A3 (en) Methods for diagnosing pancreatic cancer
WO2008109075A3 (en) Biomarkers and methods for determining sensitivity to ctla-4 antagonists
WO2013093635A3 (en) Plasma micrornas for the detection of early colorectal cancer
RU2018124339A (ru) Способ и система для сенсорного обнаружения посредством модифицированной наноструктуры
WO2013049782A3 (en) System, apparatus and method for evaluating samples or analytes using a point-of-care device
WO2006020579A3 (en) Method for rapid identification of microorganisms
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
EP3156925A3 (en) Copd biomarker signatures
MX2021008520A (es) Metodos y sistemas para deteccion de analitos.
WO2010009074A3 (en) Method for predicting and detecting tumor metastasis
WO2007005666A3 (en) System and method of analyte detection using differential receptors
ATE467831T1 (de) Verfahren und vorrichtung zum nachweis flüchtiger analyten in luftproben
WO2003102015A3 (en) Method and apparatus for detecting and monitoring peptides, and peptides identified therewith
IL189185A0 (en) Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
WO2005050203A3 (en) The methods for screening using ctgf and trka receptor for the identification of compounds for use in treatment of fibrosis
WO2008131261A3 (en) Peptide biomarkers of cardiovascular disease
WO2014044791A3 (en) Methods and kits for predicting the sensitivity of a subject to chemotherapy
WO2007062142A3 (en) Method for identifying biomarkers associated with cancer
WO2005074522A3 (en) Detection of ruminant dna via pcr
DK1416278T3 (da) Fremgangsmåder til forbedret diagnosticering af dysplasier
FI20011908A0 (fi) Menetelmä vatsasyövän osoittamiseksi
WO2004097030A3 (en) Prognostic breast cancer biomarkers